Boeder Schafer C相关文献与解析，生知库 | 链接生命科学的每一步

Continuous Glucose Monitoring-Guided Insulin Infusion in Critically Ill Patients Promotes Safety, Improves Time Efficiency, and Enhances Provider Satisfaction

在危重患者中，持续血糖监测指导下的胰岛素输注可提高安全性、提升时间效率并增强医护人员满意度。

doi:10.1016/j.eprac.2025.05.751

Giovannetti, Erin R; Lee, Rachael O; Thomas, Robert L; Wolinsky, Tamar; Talbot, Adrianne V; Ali, Rabia S; Cavaiola, Tricia Santos; Kulasa, Kristen; Boeder, Schafer C

免疫/内分泌

发表日期：2025

文献求助收藏

Accuracy of Factory-Calibrated Continuous Glucose Monitors in Critically Ill Patients Receiving Intravenous Insulin: A Prospective Clinical Trial of Two Leading Systems

工厂校准的连续血糖监测仪在接受静脉胰岛素治疗的危重患者中的准确性：两种领先系统的前瞻性临床试验

期刊:Journal of diabetes science and technology

影响因子:3.7

doi:10.1177/19322968251338865

Ramesh, Gautam; Kobayashi, Emily; Sharma, Navyaa; Majithia, Amit R; Kulasa, Kristen; Boeder, Schafer C

免疫/内分泌

发表日期：2025

文献求助收藏

Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial

SGLT2抑制剂和胰高血糖素受体拮抗剂联合治疗1型糖尿病：一项随机临床试验

期刊:

影响因子:

doi:10.2337/dc24-0212

Boeder, Schafer C; Thomas, Robert L; Le Roux, Melissa J; Giovannetti, Erin R; Gregory, Justin M; Pettus, Jeremy H

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

持续血糖监测低于目标值的时间可预测1型糖尿病患者对低血糖的肾上腺素反应受损

期刊:

影响因子:

doi:10.2337/dc23-2501

Thomas, Robert L; Boeder, Schafer C; Hamidi, Vala; Giovannetti, Erin R; Gregory, Justin M; Pettus, Jeremy H

Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.

虾青素是一种天然抗氧化剂，可以降低糖尿病前期和血脂异常患者的胆固醇和心血管风险指标

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.15070

Ciaraldi Theodore P, Boeder Schafer C, Mudaliar Sunder R, Giovannetti Erin R, Henry Robert R, Pettus Jeremy H

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

胰高血糖素受体拮抗剂volagidemab治疗1型糖尿病：一项为期12周的随机、双盲、II期试验

期刊:Nature Medicine

影响因子:50

doi:10.1038/s41591-022-02011-x

Pettus, Jeremy; Boeder, Schafer C; Christiansen, Mark P; Denham, Douglas S; Bailey, Timothy S; Akturk, Halis K; Klaff, Leslie J; Rosenstock, Julio; Cheng, Mickie H M; Bode, Bruce W; Bautista, Edgar D; Xu, Ren; Yan, Hai; Thai, Dung; Garg, Satish K; Klein, Samuel

Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes

肝选择性葡萄糖激酶激活剂TTP399对1型糖尿病患者停用胰岛素期间酮症酸中毒的影响

期刊:Diabetes Obesity & Metabolism

影响因子:5.7

doi:10.1111/dom.14697

Klein, Klara R; Boeder, Schafer C; Freeman, Jennifer L R; Dunn, Imogene; Dvergsten, Chris; Madduri, Supradeep; Giovannetti, Erin R; Valcarce, Carmen; Buse, John B; Pettus, Jeremy H

Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1

乙酰唑胺治疗对非蛋白尿型1型糖尿病患者肾功能的影响

Continuous Glucose Monitoring-Guided Insulin Infusion in Critically Ill Patients Promotes Safety, Improves Time Efficiency, and Enhances Provider Satisfaction

在危重患者中，持续血糖监测指导下的胰岛素输注可提高安全性、提升时间效率并增强医护人员满意度。

Accuracy of Factory-Calibrated Continuous Glucose Monitors in Critically Ill Patients Receiving Intravenous Insulin: A Prospective Clinical Trial of Two Leading Systems

工厂校准的连续血糖监测仪在接受静脉胰岛素治疗的危重患者中的准确性：两种领先系统的前瞻性临床试验

Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial

SGLT2抑制剂和胰高血糖素受体拮抗剂联合治疗1型糖尿病：一项随机临床试验

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

持续血糖监测低于目标值的时间可预测1型糖尿病患者对低血糖的肾上腺素反应受损

Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia.

虾青素是一种天然抗氧化剂，可以降低糖尿病前期和血脂异常患者的胆固醇和心血管风险指标

Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial

胰高血糖素受体拮抗剂volagidemab治疗1型糖尿病：一项为期12周的随机、双盲、II期试验

Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes

肝选择性葡萄糖激酶激活剂TTP399对1型糖尿病患者停用胰岛素期间酮症酸中毒的影响